Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1996 Aug;74(4):496–501. doi: 10.1038/bjc.1996.392

Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.

M K Parmar, L A Stewart, D G Altman
PMCID: PMC2074669  PMID: 8761361

Full text

PDF
496

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Begg C. B., Engstrom P. F. Eligibility and extrapolation in cancer clinical trials. J Clin Oncol. 1987 Jun;5(6):962–968. doi: 10.1200/JCO.1987.5.6.962. [DOI] [PubMed] [Google Scholar]
  2. Bobbio M., Demichelis B., Giustetto G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet. 1994 May 14;343(8907):1209–1211. doi: 10.1016/s0140-6736(94)92407-4. [DOI] [PubMed] [Google Scholar]
  3. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2. [DOI] [PubMed] [Google Scholar]
  4. Dickersin K., Scherer R., Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994 Nov 12;309(6964):1286–1291. doi: 10.1136/bmj.309.6964.1286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gray R., James R., Mossman J., Stenning S. AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee. Br J Cancer. 1991 Jun;63(6):841–845. doi: 10.1038/bjc.1991.187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gregory W. M., Richards M. A., Malpas J. S. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol. 1992 Feb;10(2):334–342. doi: 10.1200/JCO.1992.10.2.334. [DOI] [PubMed] [Google Scholar]
  7. Gøtzsche P. C. Reference bias in reports of drug trials. Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):654–656. [PMC free article] [PubMed] [Google Scholar]
  8. Himel H. N., Liberati A., Gelber R. D., Chalmers T. C. Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials. JAMA. 1986 Sep 5;256(9):1148–1159. doi: 10.1001/jama.256.9.1148. [DOI] [PubMed] [Google Scholar]
  9. King J. F., Grant A., Keirse M. J., Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol. 1988 Mar;95(3):211–222. doi: 10.1111/j.1471-0528.1988.tb06860.x. [DOI] [PubMed] [Google Scholar]
  10. Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987 Apr-May;6(3):233–244. doi: 10.1002/sim.4780060306. [DOI] [PubMed] [Google Scholar]
  11. Pignon J. P., Arriagada R., Ihde D. C., Johnson D. H., Perry M. C., Souhami R. L., Brodin O., Joss R. A., Kies M. S., Lebeau B. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992 Dec 3;327(23):1618–1624. doi: 10.1056/NEJM199212033272302. [DOI] [PubMed] [Google Scholar]
  12. Simon R., Altman D. G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994 Jun;69(6):979–985. doi: 10.1038/bjc.1994.192. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Simon R. The role of overviews in cancer therapeutics. Stat Med. 1987 Apr-May;6(3):389–396. doi: 10.1002/sim.4780060335. [DOI] [PubMed] [Google Scholar]
  14. Slevin M. L., Stubbs L., Plant H. J., Wilson P., Gregory W. M., Armes P. J., Downer S. M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990 Jun 2;300(6737):1458–1460. doi: 10.1136/bmj.300.6737.1458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stewart L. A., Clarke M. J. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995 Oct 15;14(19):2057–2079. doi: 10.1002/sim.4780141902. [DOI] [PubMed] [Google Scholar]
  16. Stewart L. A., Parmar M. K. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 1993 Feb 13;341(8842):418–422. doi: 10.1016/0140-6736(93)93004-k. [DOI] [PubMed] [Google Scholar]
  17. Thompson S. G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994 Nov 19;309(6965):1351–1355. doi: 10.1136/bmj.309.6965.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES